Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 12

    Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

    Coronavirus Scare: Minister apprises parliament about the availability of drugs and shortages

    Medical Dialogues Bureau14 March 2020 3:03 PM IST
    Delhi: Through a written reply in the Rajya Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament that...
    9 Biotechnology parks operative in states, providing support to scientists, SMEs

    9 Biotechnology parks operative in states, providing support to scientists, SMEs

    Medical Dialogues Bureau14 March 2020 2:58 PM IST
    New Delhi: There are 9 Biotechnology parks in various states, Dr Harsh Vardhan, Minister of Science & Technology, Health and Family Welfare and...
    AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules

    AstraZeneca Pharma India gets DCGI nod for Calquence-Acalabrutinib 100mg capsules

    Medical Dialogues Bureau14 March 2020 12:03 PM IST
    Acalabrutinib 100mg capsules are indicated for the treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).
    Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

    Janssen pharma collaborates with Beth Israel Deaconess Medical Center for COVID-19 Vaccine Development

    Medical Dialogues Bureau14 March 2020 9:30 AM IST
    Janssen's vaccine program will use the Janssen AdVac® and PER.C6® technologies that provide the ability to rapidly upscale production of an optimal...
    SMS Pharmaceuticals gets EIR from USFDA for Kandivalasa facility

    SMS Pharmaceuticals gets EIR from USFDA for Kandivalasa facility

    Medical Dialogues Bureau13 March 2020 2:23 PM IST
    India: SMS Pharmaceuticals has announced the successful closure of inspection with the receipt of Establishment Inspection Report (EIR) from the...
    Lupin Receives International Sustainability Rating System (ISRS) Certification

    Lupin Receives International Sustainability Rating System (ISRS) Certification

    Medical Dialogues Bureau13 March 2020 12:20 PM IST
    Mumbai: Pharma major Lupin Limited has announced that the Company has received certification for International Sustainability Rating System (ISRS),...
    Tiziana Life Sciences plc to expedite development of TZLS-501 for  COVID-19

    Tiziana Life Sciences plc to expedite development of TZLS-501 for COVID-19

    Medical Dialogues Bureau13 March 2020 11:15 AM IST
    Tiziana's anti-IL-6R mAb binds to both the membrane-bound and soluble forms of IL-6R and rapidly depletes circulating levels of IL-6 in the blood.
    Thermo Fisher Scientific collaborates with Janssen to Develop Companion Diagnostic for Cancer

    Thermo Fisher Scientific collaborates with Janssen to Develop Companion Diagnostic for Cancer

    Medical Dialogues Bureau13 March 2020 9:30 AM IST
    Oncomine Dx Target Test is a next-generation sequencing (NGS) assay that contains 46 cancer-related biomarkers and a workflow that features a fast...
    AbCellera, Eli Lilly join hands for Antibody Therapies for COVID-19

    AbCellera, Eli Lilly join hands for Antibody Therapies for COVID-19

    Medical Dialogues Bureau13 March 2020 9:00 AM IST
    Vancouver and Indianapolis: AbCellera and Eli Lilly and Company have recently announced that they have entered into an agreement to co-develop...
    ISO Biocompatibility Quality Standards to compile with Trivitron Kiran Radiation Protection Products

    ISO Biocompatibility Quality Standards to compile with Trivitron Kiran Radiation Protection Products

    Medical Dialogues Bureau12 March 2020 3:58 PM IST
    New Delhi: Trivitron Healthcare's Imaging Division, Kiran Medical Systems has announced that its all components that can come in contact with the...
    US Patent grants Cellectis to cover CRISPR-Edited Allogeneic CAR T-Cells

    US Patent grants Cellectis to cover CRISPR-Edited Allogeneic CAR T-Cells

    Medical Dialogues Bureau12 March 2020 3:57 PM IST
    New York: Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells...
    Qiagen boosting production of chemical needed to test for coronavirus

    Qiagen boosting production of chemical needed to test for coronavirus

    Medical Dialogues Bureau12 March 2020 1:29 PM IST
    Germany: German molecular testing company Qiagen has said on Wednesday it was ramping up production of a chemical used in some coronavirus tests,...
    PrevNext

    Popular Stories

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Jubilant Life Sciences Q3 profit falls 23.97pc at Rs 203.38 crore

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    Indian Genetics startup MedGenome raises Rs 415 crore in funding led by LeapFrog Investments

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok